Technical Analysis for FLGT - Fulgent Genetics, Inc.

Grade Last Price % Change Price Change
C 69.24 4.54% 3.01
FLGT closed up 4.54 percent on Friday, January 22, 2021, on 54 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up
Historical FLGT trend table...

Date Alert Name Type % Chg
180 Bullish Setup Bullish Swing Setup 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
NR7 Range Contraction 0.00%
Inside Day Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Slingshot Bullish Bullish Swing Setup 4.54%
Multiple of Ten Bearish Other 4.54%
Wide Bands Range Expansion 4.54%
Overbought Stochastic Strength 4.54%
Bearish Engulfing Bearish -0.35%
Older End-of-Day Signals for FLGT ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
60 Minute Opening Range Breakout about 13 hours ago
Rose Above 10 DMA about 13 hours ago
10 DMA Resistance about 18 hours ago
Up 3% about 19 hours ago
Up 2% about 19 hours ago
View Earlier Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Fulgent Genetics, Inc. Description

Fulgent Genetics, Inc. is a technology company. The Company offers genetic testing to provide physicians with clinically actionable diagnostic information to improve quality of patient care. The Company has developed a technology platform that integrates data comparison and suppression algorithms, adaptive learning software, advanced genetic diagnostics tools and integrated laboratory processes. As of December 31, 2015, the Company's test menu includes approximately 18,000 single-gene tests and over 200 pre-established, multi-gene, disease-specific panels that collectively test for approximately 7,500 genetic conditions, including various cancers, cardiovascular diseases and neurological disorders. The Company's gene probes are specifically engineered to generate genetic data that is optimized for its software, which enables to rapidly incorporate new genes into its test menu, develop new panels of disease-specific tests and customize tests for its customers.


Classification

Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Medicine Biotechnology Cancers Genetics Cardiovascular Disease Medical Genetics Medical Tests Algorithms Neurological Disorders Vascular Diseases Molecular Diagnostics Cardiovascular Diseases Urological Disorders Applied Genetics Genetic Testing Adaptive Learning Qiagen Alternatives To Animal Testing

Is FLGT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 79.63
52 Week Low 6.7
Average Volume 2,068,237
200-Day Moving Average 32.70
50-Day Moving Average 50.99
20-Day Moving Average 61.91
10-Day Moving Average 68.66
Average True Range 6.09
ADX 29.65
+DI 27.45
-DI 17.60
Chandelier Exit (Long, 3 ATRs ) 61.37
Chandelier Exit (Short, 3 ATRs ) 60.77
Upper Bollinger Band 80.91
Lower Bollinger Band 42.91
Percent B (%b) 0.69
BandWidth 61.38
MACD Line 6.14
MACD Signal Line 6.13
MACD Histogram 0.0098
Fundamentals Value
Market Cap 1.68 Billion
Num Shares 24.3 Million
EPS 2.14
Price-to-Earnings (P/E) Ratio 32.36
Price-to-Sales 7.56
Price-to-Book 5.95
PEG Ratio 1.32
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 74.45
Resistance 3 (R3) 73.94 71.71 73.58
Resistance 2 (R2) 71.71 70.38 71.96 73.29
Resistance 1 (R1) 70.47 69.56 71.09 70.98 73.00
Pivot Point 68.24 68.24 68.55 68.49 68.24
Support 1 (S1) 67.00 66.91 67.62 67.51 65.48
Support 2 (S2) 64.77 66.09 65.02 65.19
Support 3 (S3) 63.53 64.77 64.90
Support 4 (S4) 64.04